459 related articles for article (PubMed ID: 7679050)
41. Identification of a novel cancer-specific immunodominant glycopeptide epitope in the MUC1 tandem repeat.
Tarp MA; Sørensen AL; Mandel U; Paulsen H; Burchell J; Taylor-Papadimitriou J; Clausen H
Glycobiology; 2007 Feb; 17(2):197-209. PubMed ID: 17050588
[TBL] [Abstract][Full Text] [Related]
42. Sialyl Lewis(x) antigen as defined by monoclonal antibody AM-3 is a marker of dysplasia in the colonic adenoma-carcinoma sequence.
Hanisch FG; Hanski C; Hasegawa A
Cancer Res; 1992 Jun; 52(11):3138-44. PubMed ID: 1350509
[TBL] [Abstract][Full Text] [Related]
43. Epithelial mucin-1 (MUC1) expression and MA5 anti-MUC1 monoclonal antibody targeting in multiple myeloma.
Burton J; Mishina D; Cardillo T; Lew K; Rubin A; Goldenberg DM; Gold DV
Clin Cancer Res; 1999 Oct; 5(10 Suppl):3065s-3072s. PubMed ID: 10541345
[TBL] [Abstract][Full Text] [Related]
44. Monoclonal antibodies against partially deglycosylated colon cancer mucin that recognize Tn antigen.
Huang J; Byrd JC; Siddiki B; Yuan M; Lau E; Kim YS
Dis Markers; 1992; 10(2):81-94. PubMed ID: 1281060
[TBL] [Abstract][Full Text] [Related]
45. Expression of mucin genes and carbohydrate epitopes in 19 human colon carcinoma cell lines.
Iida S; Tsuiji H; Nemoto Y; Sano Y; Reddish MA; Irimura T
Oncol Res; 1998; 10(8):407-14. PubMed ID: 10100757
[TBL] [Abstract][Full Text] [Related]
46. Carbohydrate epitopes and mucins expressed by 17 human ovarian carcinoma cell lines.
Tamada Y; Iida S; Aoki D; Nozawa S; Irimura T
Oncol Res; 1999; 11(5):233-41. PubMed ID: 10608618
[TBL] [Abstract][Full Text] [Related]
47. Multiple forms of intracellular and secreted mucins in a pancreatic cancer cell line.
Ho JJ; Bi N; Siddiki B; Chung YS; Yuan M; Kim YS
Cancer Res; 1993 Feb; 53(4):884-90. PubMed ID: 7679052
[TBL] [Abstract][Full Text] [Related]
48. MUC1 synthetic peptide inhibition of intercellular adhesion molecule-1 and MUC1 binding requires six tandem repeats.
Kam JL; Regimbald LH; Hilgers JH; Hoffman P; Krantz MJ; Longenecker BM; Hugh JC
Cancer Res; 1998 Dec; 58(23):5577-81. PubMed ID: 9850097
[TBL] [Abstract][Full Text] [Related]
49. Tumor cell MUC1 and CD43 are glycosylated differently with sialyl-Lewis a and x epitopes and show variable interactions with E-selectin under physiological flow conditions.
Fernandez-Rodriguez J; Dwir O; Alon R; Hansson GC
Glycoconj J; 2001; 18(11-12):925-30. PubMed ID: 12820726
[TBL] [Abstract][Full Text] [Related]
50. Mucin-like carcinoma-associated antigen defined by three monoclonal antibodies against different epitopes.
Stähli C; Caravatti M; Aeschbacher M; Kocyba C; Takacs B; Carmann H
Cancer Res; 1988 Dec; 48(23):6799-802. PubMed ID: 2460229
[TBL] [Abstract][Full Text] [Related]
51. Novel adapter protein AP162 connects a sialyl-Le(x)-positive mucin with an apoptotic signal transduction pathway.
Hartel-Schenk S; Gratchev A; Hanski ML; Ogorek D; Trendelenburg G; Hummel M; Höpfner M; Scherübl H; Zeitz M; Hanski C
Glycoconj J; 2001; 18(11-12):915-23. PubMed ID: 12820725
[TBL] [Abstract][Full Text] [Related]
52. A straightforward protocol for the preparation of high performance microarray displaying synthetic MUC1 glycopeptides.
Matsushita T; Takada W; Igarashi K; Naruchi K; Miyoshi R; Garcia-Martin F; Amano M; Hinou H; Nishimura S
Biochim Biophys Acta; 2014 Mar; 1840(3):1105-16. PubMed ID: 24246952
[TBL] [Abstract][Full Text] [Related]
53. Reactivity of antibodies with highly glycosylated MUC1 mucins from colon carcinoma cells and bile.
Sikut R; Sikut A; Zhang K; Baeckström D; Hansson GC
Tumour Biol; 1998; 19 Suppl 1():122-6. PubMed ID: 9422097
[TBL] [Abstract][Full Text] [Related]
54. Monoclonal antibodies reactive with mucin glycoproteins found in sera from breast cancer patients.
Linsley PS; Brown JP; Magnani JL; Horn D
Cancer Res; 1988 Apr; 48(8):2138-48. PubMed ID: 2450646
[TBL] [Abstract][Full Text] [Related]
55. Identification of the gastrointestinal and pancreatic cancer-associated antigen detected by monoclonal antibody 19-9 in the sera of patients as a mucin.
Magnani JL; Steplewski Z; Koprowski H; Ginsburg V
Cancer Res; 1983 Nov; 43(11):5489-92. PubMed ID: 6193872
[TBL] [Abstract][Full Text] [Related]
56. Studies on the order and site specificity of GalNAc transfer to MUC1 tandem repeats by UDP-GalNAc: polypeptide N-acetylgalactosaminyltransferase from milk or mammary carcinoma cells.
Stadie TR; Chai W; Lawson AM; Byfield PG; Hanisch FG
Eur J Biochem; 1995 Apr; 229(1):140-7. PubMed ID: 7744025
[TBL] [Abstract][Full Text] [Related]
57. Characterization of a new MUC1 monoclonal antibody (VU-2-G7) directed to the glycosylated PDTR sequence of MUC1.
Ryuko K; Schol DJ; Snijdewint FG; von Mensdorff-Pouilly S; Poort-Keesom RJ; Karuntu-Wanamarta YA; Verstraeten RA; Miyazaki K; Kenemans P; Hilgers J
Tumour Biol; 2000; 21(4):197-210. PubMed ID: 10867613
[TBL] [Abstract][Full Text] [Related]
58. Immunoreactivity of Lewis blood group and mucin peptide core antigens: correlations with grade of dysplasia and malignant transformation in the colorectal adenoma-carcinoma sequence.
Baldus SE; Hanisch FG; Pütz C; Flucke U; Mönig SP; Schneider PM; Thiele J; Hölscher AH; Dienes HP
Histol Histopathol; 2002 Jan; 17(1):191-8. PubMed ID: 11813869
[TBL] [Abstract][Full Text] [Related]
59. Immune recognition of linear epitopes in peptide fragments of epithelial mucins.
Briggs S; Price MR; Tendler SJ
Immunology; 1991 Aug; 73(4):505-7. PubMed ID: 1717370
[TBL] [Abstract][Full Text] [Related]
60. Post-translational fate of a mucin-like leukocyte sialoglycoprotein (CD43) aberrantly expressed in a colon carcinoma cell line.
Baeckström D
J Biol Chem; 1997 Apr; 272(17):11503-9. PubMed ID: 9111064
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
